Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Laida Pharmaceutical is a comprehensive pharmaceutical enterprise based in Huizhou, China, focused on the development, production, and sale of chemical drugs and traditional Chinese medicine. The company maintains a diverse product portfolio that includes antibiotics, cardiovascular medications, and treatments for respiratory and digestive ailments. Operating out of a large-scale, GMP-certified manufacturing base, Laida Pharmaceutical produces several well-known generic formulations such as Amoxicillin and Metformin. The firm is recognized as a High-Tech Enterprise in Guangdong Province and emphasizes quality control and technological innovation in its manufacturing processes. Its products are widely distributed across China, serving both hospital and retail pharmacy channels. Through its commitment to providing high-quality and accessible healthcare solutions, Laida Pharmaceutical has established itself as a significant player in the regional life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Laida Pharmaceutical.